Drugmaker Novo Nordisk warns of U.S. legislation, cautious on 2018

COPENHAGEN (Reuters) - Drugmaker Novo Nordisk forecast only muted growth in 2018 and warned that draft legislation in some U.S. states to make pricing more transparent could impact business in its largest market.

from Reuters: Health News http://ift.tt/2iU3yHr